P

Inventor

SALTER RHYS

US31 patents
⚠️ This page may combine multiple inventors who share the name “SALTER RHYS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

24 patents
US9850318B2Dec 26, 2017

Antibodies to quetiapine haptens and use thereof

JANSSEN PHARMACEUTICA NV16 citations92
US9795685B2Oct 24, 2017

Haptens of aripiprazole

JANSSEN PHARMACEUTICA NV17 citations92
US9611332B2Apr 4, 2017

Antibodies to aripiprazole haptens and use thereof

JANSSEN PHARMACEUTICA NV18 citations92
US9504682B2Nov 29, 2016

Haptens of aripiprazole

JANSSEN PHARMACEUTICA NV17 citations92
US9303041B2Apr 5, 2016

Haptens of olanzapine

JANSSEN PHARMACEUTICA NV17 citations83
US9304126B2Apr 5, 2016

Haptens of quetiapine

JANSSEN PHARMACEUTICA NV17 citations83
US9611259B2Apr 4, 2017

Substituted pyridine derivatives useful as C-FMS kinase inhibitors

JANSSEN PHARMACEUTICA NV3 citations71
US11226345B2Jan 18, 2022

Antibodies to olanzapine haptens and use thereof

JANSSEN PHARMACEUTICA NV0 citations62
US11105793B2Aug 31, 2021

Antibodies to aripiprazole haptens and use thereof

JANSSEN PHARMACEUTICA NV0 citations62
US10175257B2Jan 8, 2019

Antibodies to aripiprazole and use thereof

JANSSEN PHARMACEUTICA NV1 citations62
US11104742B2Aug 31, 2021

Antibodies to quetiapine and use thereof

JANSSEN PHARMACEUTICA NV0 citations61
US11046786B2Jun 29, 2021

Antibodies to olanzapine and use thereof

JANSSEN PHARMACEUTICA NV0 citations61
US11214566B2Jan 4, 2022

Substituted pyridine derivatives useful as C-FMS kinase inhibitors

JANSSEN PHARMACEUTICA NV0 citations60
US10816561B2Oct 27, 2020

Antibodies to aripiprazole and use thereof

JANSSEN PHARMACEUTICA NV0 citations52
US10488401B2Nov 26, 2019

Antibodies to aripiprazole haptens and use thereof

JANSSEN PHARMACEUTICA NV0 citations52
US10379105B2Aug 13, 2019

Antibodies to aripiprazole haptens and use thereof

JANSSEN PHARMACEUTICA NV0 citations52
US10166296B2Jan 1, 2019

Haptens of aripiprazole

JANSSEN PHARMACEUTICA NV0 citations52
US10712353B2Jul 14, 2020

Antibodies to olanzapine haptens and use thereof

JANSSEN PHARMACEUTICA NV0 citations51
US10465013B2Nov 5, 2019

Antibodies to quetiapine haptens and use thereof

JANSSEN PHARMACEUTICA NV0 citations51
US10435478B2Oct 8, 2019

Antibodies to quetiapine and use thereof

JANSSEN PHARMACEUTICA NV0 citations51
US10344098B2Jul 9, 2019

Antibodies to olanzapine and use thereof

JANSSEN PHARMACEUTICA NV0 citations51
US10288631B2May 14, 2019

Antibodies to quetiapine and use thereof

JANSSEN PHARMACEUTICA NV0 citations51
US10800764B2Oct 13, 2020

Substituted pyridine derivatives useful as C-FMS kinase inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US10071991B2Sep 11, 2018

Substituted pyridine derivatives useful as c-fms kinase inhibitors

JANSSEN PHARMACEUTICA NV0 citations50

ORTHO CLINICAL DIAGNOSTICS INC

3 patents

JANSSEN BIOTECH INC

3 patents

NOVARTIS AG

1 patent